|
|
Article: Sepracor Announces First Quarter 2005 Operating Results.
- Article from:
- PR Newswire
- Article date:
- April 25, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MARLBOROUGH, Mass., April 25 /PRNewswire-FirstCall/ -- Sepracor Inc. today announced its consolidated financial results for the first quarter of 2005. For the three months ended March 31, 2005, Sepracor's consolidated revenues were approximately $119.0 million, of which revenues from pharmaceutical product sales (XOPENEX(R) Inhalation Solution) were approximately $106.6 million. The net loss for the first quarter of 2005 was approximately $22.6 million, or $0.22 per share. These consolidated results compare with consolidated revenues of $99.5 million, of which revenues from pharmaceutical product sales (XOPENEX Inhalation Solution) were approximately $85.1 million, and ...